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Hematopoietic stem cells (HSCs) maintain homeo-
stasis and regenerate the blood system throughout
life. It has been postulated that HSCs may be
uniquely capable of preserving their genomic integ-
rity in order to ensure lifelong function. To directly
test this, we quantified DNA damage in HSCs and
downstream progenitors from young and old mice,
revealing that strand breaks significantly accrue in
HSCs during aging. DNA damage accumulation in
HSCs was associated with broad attenuation of
DNA repair and response pathways that was depen-
dent upon HSC quiescence. Accordingly, cycling
fetal HSCs and adult HSCs driven into cycle upregu-
lated these pathways leading to repair of strand
breaks. Our results demonstrate that HSCs are
not comprehensively geno-protected during aging.
Rather, HSC quiescence and concomitant attenua-
tion of DNA repair and response pathways underlies
DNA damage accumulation in HSCs during aging.
These results provide a potential mechanism through
which premalignant mutations accrue in HSCs.
INTRODUCTION
Aging of the hematopoietic system is associated with many
changes, including diminished lymphoid potential, elevated
autoimmunity, reduced regenerative potential, and onset of a
spectrum of hematopoietic diseases including myelodysplastic
syndrome and leukemias. Mounting evidence suggests that ag-
ing-associated changes in hemopoietic stem cells (HSCs) auton-
omously contribute to many of these age-related phenotypes
throughdiversemechanisms involvingdiminution of regenerative
potential (Dykstra et al., 2011; Rossi et al., 2005; Sudo et al.,
2000), changes in lineage potential and HSC subtype composi-
tion (Beerman et al., 2010; Challen et al., 2010; Dykstra et al.,2011; Pang et al., 2011), loss of polarity (Florian et al., 2012), alter-
ations of the epigenetic landscape (Beerman et al., 2013; Cham-
bers et al., 2007), and DNA damage accumulation (Rossi et al.,
2007a; Ru¨be et al., 2011). Both myelodysplastic syndrome
(Panget al., 2013) andacute andchronicmyelogenous leukemias
begin with nonlethal mutations in the HSC pool, often leading to
successful expansion of mutant HSC clones at the expense of
normal HSCs and that eventually progress to leukemia (Corces-
Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012).
It has been postulated that tissue-specific stem cells,
including HSCs, must possess cyto- and geno-protective mech-
anisms in order to ensure their long-term functional potential.
Consistent with this idea, HSCs are imbued with a number of
protective properties that are believed to contribute to the
preservation of their activity. For example, the high levels of
expression of certain ATP binding cassette (ABC) trans-
porters, including ABCG2, confer xenobiotic efflux activity on
HSCs (Krishnamurthy et al., 2004; Zhou et al., 2001, 2002).
HSCs also maintain low levels of reactive oxygen species due
to the combined action of their low metabolic activity and
their reliance on glycolytic metabolism along with the inherent
hypoxic nature of HSCs and their niche (Kocabas et al., 2012;
Nombela-Arrieta et al., 2013; Parmar et al., 2007; Shyh-Chang
et al., 2013; Suda et al., 2011; Takubo et al., 2010). Moreover,
the dormant nature of HSCs (Cheshier et al., 1999; Foudi et al.,
2009; Wilson et al., 2008), combined with the expression of
telomerase in HSCs (Broccoli et al., 1995; Hiyama et al., 1995;
Morrison et al., 1996), minimizes the introduction of replication-
based errors and uncapping of telomeres during replication
(Allsopp et al., 2003; Flores et al., 2006; Morrison et al., 1996).
In addition to these inherent cyto-protective properties, it is
also clear that genome repair is important for HSC regenerative
potential, as highlighted in studies using mice with engineered
mutations in diverse DNA repair and response pathways, that
invariably show diminished HSC functional potential under con-
ditions of stress (Cho et al., 2013; Nijnik et al., 2007; Parmar et al.,
2010; Prasher et al., 2005; Rossi et al., 2007a). The aging depen-
dent exacerbation of functional deficits in several DNA-repair-
deficient mice suggested that the physiologic process of aging
may be associated with progressive DNA damage accrual inCell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc. 37
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Figure 1. DNA Damage Accumulates in HSCs during Aging
(A) Representative alkaline comets of young and old HSCs.
(B and C) Olive tail moment (B) and percent of DNA in tail (C) of 710 HSCs from young mice, 447 HSCs from old mice, and 77 HSCs dosed with 2 Gy of irradiation.
***p < 0.001.
Error bars represent SEM. See also Figure S1 and Table S1.
Cell Stem Cell
Quiescence Underlies Damage Accrual in Aged HSCsHSCs (Nijnik et al., 2007; Rossi et al., 2007a). Indeed, this idea
has been supported by immunohistochemical evidence of
gH2AX accumulation, an indicator of DNA damage response
(DDR), in HSCs isolated from old mice (Rossi et al., 2007a) and
aged humans (Ru¨be et al., 2011). It has been proposed that
diminished DNA repair capacity may underlie this age-associ-
ated DNA damage accrual (Chambers et al., 2007; Ru¨be et al.,
2011), although this hypothesis has not been directly tested.
Herein, we present direct evidence of DNA damage accumu-
lation in HSCs during aging. We report that, among diverse
hematopoietic progenitor cells, age-associated DNA damage
accrual measured by comet assays of DNA strand breaks is
greatest within the HSC compartment. However, when HSCs
are brought into cycle, the accrued damage does not result in
measurable cell death, inability to produce hematopoietic col-
onies in vitro, or failure to reconstitute blood cells in vivo. Utilizing
microarray expression analysis, we show that multiple DDR and
repair pathways are broadly attenuated in quiescent, but not
cycling, HSCs.We show that HSCs stimulated to enter cell-cycle
upregulate multiple DNA response and repair pathways and
concomitantly repair accumulated DNA damage. Altogether,38 Cell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc.our results refute the doctrine that HSCs are uniquely geno-
protected during aging and instead demonstrates that stem
cell quiescence attenuates DNA repair and response pathways
in HSCs leading to DNA damage accumulation in the hematopoi-
etic stem cell compartment during aging.
RESULTS
DNA Damage Accumulates in HSCs during Aging
Immunostaining of gH2AX in human and murine hematopoietic
progenitors has provided indirect evidence that DNA strand
breaks may accrue in HSCs during aging (Rossi et al., 2007a;
Ru¨be et al., 2011). However, it remains possible that the
observed gH2AX foci in aged stem cells may mark cellular pro-
cesses distinct from DNA damage. Therefore, we sought to
directly evaluate and quantify DNA damage in HSCs and progen-
itors during aging. To this end, we used alkaline comet assays
(Figure S1 available online) (Olive and Bana´th, 2006; Olive
et al., 2001; Singh et al., 1988) to measure single- and double-
strand breaks in stringently purified HSCs from young
(3–4 months) and old (24–26 months) mice (Figure 1A). HSCs
Cell Stem Cell
Quiescence Underlies Damage Accrual in Aged HSCssubjected to gamma irradiation were assayed in parallel as a
positive control. Analysis of the two most reliable DNA damage
measurements, Olive moment and percent tail DNA (Kumaravel
and Jha, 2006), showed significantly elevated levels of DNA
damage in HSCs purified from old mice in comparison to young
HSCs (Figures 1B and 1C). These data were verified in six inde-
pendent experiments in which a cumulative total of 4,940
young and 3,186 old HSCs with the immunophenotype of
LSKCD34Flk2 were scored in a blinded fashion. In two addi-
tional experiments, we assayed comets of over 2,000 young
and old HSCs purified with an alternative cell-surface marker
combination for HSCs: LSKCD150+CD48 (Kiel et al., 2005). In
all experiments, a highly significant increase in DNA breaks
was observed in old HSCs (Table S1). Interestingly, we consis-
tently observed that young HSCs are not impervious to DNA
damage, and 33% showed evidence of single- or double-strand
breaks, defined here as having greater than 10% DNA in their
comet tails (Figures 1C and S1). In contrast, 70% of old
HSCs scored as damaged (Figure 1C). Furthermore, tail DNA
analysis revealed that, although young and old HSCs showed
comparable frequencies of cells presenting evidence of modest
DNA damage (classified as 10%–30% tail DNA), cells showing
evidence of significant DNA damage (>30% tail DNA) were
muchmore prevalent in HSCs purified from old (42%) in compar-
ison to young (9%) mice (Figure 1C). Nonetheless, the fact that
over 30% of old HSCs showed no evidence of strand breaks in-
dicates that the HSC population as a whole does not compre-
hensively accrue strand breaks during aging.
To address the specificity of aging-associated damage in
hematopoietic progenitor cells, we analyzed strand breaks in
HSCs in comparison to their downstream progenitor progeny
from young and old mice. Purified multipotent (MPPFlk2 and
MPPFlk2+) and oligopotent progenitors (granulocyte-macro-
phage progenitor [GMP] and common lymphoid progenitor
[CLP]), along with HSCs, were analyzed in single-cell comet
assays. Analysis of the Olive tail moment of each downstream
progenitor populations in comparison to HSCs isolated from
young mice showed no significant differences (Figures 2A and
2B), although CLPs displayed slightly elevated Olive tail mo-
ments, possibly because of immunoglobulin heavy chain diver-
sity and joining gene segment rearrangements actively occurring
in this population. Consistent with this, the percent tail DNA of
the young progenitor populations and HSCs was comparable,
and the majority of scored cells (>70% in all populations) had
no measurable DNA damage (<10% tail DNA; Figure 2C). In
contrast, analysis of these same stem and progenitor popula-
tions from old mice (Figure 2D) demonstrated that the amount
of damage accrued in the HSC compartment was significantly
greater in comparison to all of the downstream progenitors by
either Olive tail moment (Figure 2E) or percent tail DNA (Figures
2F and S2A). Furthermore, we analyzed the Olive tail moment of
the stem and progenitor populations by comparing cells isolated
from young to those purified from old mice. As we observed
previously (Figure 1B), HSCs from old mice consistently showed
a significant increase of DNA breaks in comparison to young
(Figures S2B and S2C). Interestingly, despite the fact that all pro-
genitor populations from old mice showed significantly reduced
levels of DNA damage in comparison to aged HSCs (Figures 2E
and S2A), the majority of these aged progenitors nonethelessshowed evidence of significantly greater levels of DNA breaks
than their young counterparts (Figures S2B and S2C). Alto-
gether, these experiments show that HSCs and their progenitors
accumulate DNA breaks during aging, yet the greatest amount of
damage accrual is found within the stem cell compartment.
Old HSCs Repair DNA Damage upon Entering Cell Cycle
To establish whether old damaged HSCs could resolve accrued
DNA damage, we used fluorescence-activated cell sorting
(FACS) to purify young and old HSCs and assayed them for
strand breaks by comet assays either immediately after purifica-
tion (steady state) or 24 hr after culturing them in a cytokine-rich
media, which stimulates the quiescent cells into cycle. Aswepre-
viously observed (Figures 1, 2, and S2), HSCs at steady state
fromboth youngandoldmice presented evidence ofDNAbreaks
with significantly more damage observed in the old HSCs (Fig-
ure 3A). However, young andoldHSCs assayed 24 hr postculture
stimulation showed very similar comet profiles, and the old cells
showed significantly reduced numbers of damaged cells in com-
parison to steady state (Figure 3A). To examine howolddamaged
HSCswould respond to induced cycling in vivo, we injected aged
animals with 5-fluorouracil (5-FU), an agent that kills cycling cells
(Van Zant, 1984) and drives the quiescent HSCs into cycle (Har-
rison and Lerner, 1991). Animalswere dosed two times at 3-week
intervals, and, 3 weeks after the final 5-FU injection, the animals
were sacrificed, HSCs were purified, and alkaline comet assays
performed. These experiments revealed that old HSCs driven
into cycle by this treatment showed a significant decrease in
the levels of DNA damage in comparison to aged control HSCs
derived frommice that received PBS injections (Figure 3B). How-
ever, it is possible that the 5-FUmaydifferentially affect damaged
HSCs, soweperformedan additional in vivo experimentwhereby
we competitively transplanted 100 HSCs purified from either
young or old mice into lethally irradiated recipients and per-
formed comet assays 12 months posttransplant. This analysis
showed no significant differences in the DNA damage burden
of HSCs derived from either the young or old donor HSCs (Fig-
ure 3C). This suggests that HSCs driven into cycle by transplan-
tation repaired their accumulated DNA damage, resetting both
the young and old HSCs to a nondamaged status, and that
both young and old HSCs acquired similar levels of DNA damage
over the time course of the experiment. Nonetheless, examina-
tion of donor-derived reconstitution from old HSCs was signifi-
cantly lower in comparison to the young HSCs with a marked
myeloid bias lineage output (Figure S3), which was consistent
with previous reports (Beerman et al., 2013; Cho et al., 2008;
Rossi et al., 2005; Sudo et al., 2000; Wang et al., 2012).
The combined results of these experiments demonstrating
reduced amounts of DNA damage in aged cells stimulated to
cycle could be explained by two possibilities: (1) DNA breaks
accrued at steady state were repaired upon entry into cycle or
(2) damaged HSCs underwent apoptosis and were not scored
poststimulation. To discriminate between these possibilities,
we quantified the rate of apoptotic attrition of young and old
HSCs at a single-cell level after stimulation into cycle. To this
end, we cloned sorted HSCs from young (318 cells) and old
(337 cells) mice and scored their viability 24 hr postplating (Table
S2). These experiments revealed that all HSCs survived the first
24 hr in culture regardless of age (Figure 4A). These data supportCell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc. 39
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Figure 2. Age-Associated DNA Damage Accrual Is Greatest in the HSC Compartment
(A) Representative alkaline comets of HSCs, multipotent progenitors (MPPFlk2 and MPPFlk2+), and oligopotent progenitors (GMP and CLP) isolated from young
mice.
(B and C) Olive tail moment (B) and percent of DNA in tail (C) of HSCs (n = 1620), MPPFlk2 (n = 714), MPPFlk2+ (n = 324), GMP (n = 333), and CLP (n = 713) from
young mice. HSCs (n = 292) that received 2 Gy of irradiation were also scored.
(D) Representative alkaline comets of HSCs, multipotent progenitors (MPPFlk2 and MPPFlk2+), and oligopotent progenitors (GMP and CLP) isolated from old
mice.
(E and F) Olive tail moment (E) and percent of DNA in tail (F) of HSCs (n = 424), MPPFlk2 (n = 578), MPPFlk2+ (n = 479), GMP (n = 309), and CLP (n = 503) from old
mice. The same irradiated controls (292 HSCs with 2 Gy) are shown, given that all samples were arrayed on one slide. ***p < 0.001.
Error bars represent SEM. See also Figures S1 and S2.
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Figure 3. HSCs Recognize and Repair DNA Damage upon Stimulation into Cell Cycle Regardless of Age
(A) Olive tail moment of HSCs isolated from young and old mice at steady state (n = 749 and 694 respectively) or after 24 hr in culture (young, 24 hr [n = 385]; old,
24 hr [n = 649]). 294 irradiated HSCs were used as a positive control.
(B) Olive tail moment of aged HSCs after receiving two doses of PBS (n = 1,107) or 5-FU (n = 1,195) and irradiated control cells (n = 176).
(C) Olive tail moment of donor derived HSCs from either young donor HSCs (n = 2,310) or aged HSCs (n = 1,746) 12 months after competitive transplant and
irradiated control cells (n = 379). ***p < 0.001.
Error bars represent SEM. See also Figure S3.
Cell Stem Cell
Quiescence Underlies Damage Accrual in Aged HSCsthe idea that old HSCs repair accrued strand breaks upon entry
into cycle and do not undergo cell death during the first 24 hr
poststimulation.
To further investigate the clonal potential of young and old
HSCs, we continued to assay viability and cell division kinetics
over 6 days of culturing (Figures 4A–4C) and then scored their
colony-forming potential on day 12 (Figures 4D and 4E). Over
the 12-day course of the experiment, each of the 318 young
HSCs assayed survived (Figures 4A and 4B) and underwent
division by 48 hr (Figure 4C), with themajority of single HSCs giv-
ing rise to colonies of >30 cells by day 6 (Figure 4B) and large
colonies by day 12 (Figure 4D). Old HSCs exhibited a similar
cell division kinetic (Figure 4C), with the majority of clones giving
rise to colonies of >30 cells by day 6 (Figure 4B). However, in
contrast to the young HSCs, we observed a small number of
old clones that died after 48 hr in culture either prior to cell divi-
sion (1 of 337) or after giving rise to one or more daughter cells
(7 of 337; Figures 4A and 4B). We also observed a single aged
HSC that did not divide over the first 6 days of stimulation, sug-
gesting that this cell was growth arrested and possibly senes-
cent. Moreover, whereas the cell types present in the colonies
at day 12 were comparable, the old HSCs generally gave rise
to smaller colonies than the young HSCs (p < 0.001; Figures
4D and 4E).
Altogether, these results indicate that aged HSCs repair
accrued DNA strand breaks upon entry into cycle; however,
even after strand break repair, aged HSCs displayed diminished
proliferative potential.
Attenuated Expression of DNA Damage Repair and
Response Genes in HSCs
Our observations of significant DNA break accrual in old HSCs in
comparison to young HSCs or aged downstream progenitorcells raised the possibility that DDR and repair may be differen-
tially regulated in quiescent HSCs and their downstream progen-
itors. To explore this possibility at a global level, we generated
transcriptome-wide expression profiles of HSCs, multipotent
progenitors (MPPFlk2 and MPPFlk2+), and downstream myeloid
and lymphoid progenitors (GMP, common myeloid progenitor
[CMP], megakaryocyte-erythroid progenitor [MEP], CLP, B
cell-biased lymphoid progenitor [BLP], and pre-ProB) from
young and old mice and analyzed the expression of 190 genes
involved in DDR and repair. These included all genes associated
with DDR and checkpoint, nucleotide excision repair (NER),
mismatch repair, base excision repair, homologous recombina-
tion (HR), and nonhomologous end-joining (NHEJ) that were
represented on the arrays (Figure 5A). Strikingly, this analysis
revealed that the vast majority of genes examined were signifi-
cantly upregulated in progenitors downstream of HSCs (false
discovery rate [FDR] < 0.05, fold change > 1.5), and many key
regulators from different pathways showed highly elevated
expression in all progenitors downstream of HSCs independent
of age (Figures 5A and 5B). This highly skewed pattern of expres-
sion was very specific to these pathways as global analysis of
genes up- or downregulated in comparisons of HSCs versus
their downstream progeny generally showed comparable
numbers of genes significantly up- or downregulated in each
comparison, which was independent of age (Figure 5B).
In general, most of the genes analyzed showed consistent
expression patterns regardless of age. However, there were a
small number of geneswhose expression was significantly diver-
gent between young and old HSCs compared to progenitors.
Most strikingwas Trp53 (which encodes p53) that showed statis-
tically significant increased expression downstream of HSCs in
young mice, whereas aged progenitors had significantly dimin-
ished expression downstream of HSCs (Figure 5A). In contrast,Cell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc. 41
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Quiescence Underlies Damage Accrual in Aged HSCsWrn, which encodes the Werner syndrome homolog, showed an
opposite pattern wherein the majority of progenitors from young
mice showed significantly decreased expression in comparison
to HSCs, whereas most progenitors from old mice exhibited
significantly increased expression. To discriminate between
the possibilities that these observations were due to age-asso-
ciated changes in the HSC compartment or the progenitor cells,
we directly compared the expression profiles of the 190 genes
involved in DDR and repair pathways between young and old
HSCs (Figures S4A and S4B). Although we found a number
of age-regulated genes, which included Trp53 andWrn, the ma-
jority of genes involved in DNA damage repair and response
were not significantly age regulated in HSCs (Figure S4A).
Next, we sought to determine whether the differences we
observed in individual genes led to significant differential regula-
tion of the DNA repair and response pathways as a whole. In
comparison to HSCs, we found that most pathways were sig-
nificantly upregulated (p < 0.001) in the majority of downstream
progenitors populations examined and that attenuation of
these pathways in HSCs was largely age independent (Fig-
ure 5C). Notably, the upregulation of genes involved in HR and
DDR and checkpoints were significantly overrepresented (odds
ratio > 1, p < 0.001) in all of the progenitor populations down-
stream of HSCs. The only pathway that was not significantly
differentially regulated in HSCs and progenitor cells was NHEJ,
which remained mostly unchanged between HSCs and down-
stream progenitors in both young and old mice, consistent with
evidence suggesting that NHEJ is transcriptionally active in
HSCs (Mohrin et al., 2010). Analysis of downregulation of these
pathways in progenitors in comparison to HSCs also demon-
strated significance in a few instances, but this significance
was invariably due to an underrepresentation of downregulation
of these genes in progenitors (odds ratio < 1) in contrast to the
significant upregulation of these pathways, which was consis-
tently due to an overrepresentation of genes with significantly
increased expression (Figure 5C).
It has previously been suggested that the expression of certain
DNA repair genes are downregulated in HSCs during aging and
that this may contribute to aging-associated damage accrual
(Chambers et al., 2007; Ru¨be et al., 2011). To examine this
broadly across all DNA damage repair and response pathways,
we compared the expression of these pathways in young and old
HSCs. Although several genes from diverse pathways displayed
significant expression changes with age, analysis of the path-
ways showed that all but one of the DDR and repair pathways
were not significantly different between young and aged HSCs
(Figure S4B). The sole exception was the NER pathway (p <
0.01), which was significantly downregulated in aged HSCs.
Altogether, these results demonstrate that HSCs exhibit atten-
uated expression of most DNA damage repair and responseFigure 4. Clonal Analysis of Single HSCs from Young and Old Mice
(A) Individual HSC clones scored daily for 6 days from three youngmice and three o
(n = 1 cell) to red (n > 32 cells). Each clone was then cultured an additional 6 day
(B) Summary of clones derived from 318 young and 337 old single HSCs after 6 day
and the composite data are presented.
(C) Cell division kinetics of young and old HSCs.
(D) Overall colony size at day 12 of clones derived from single young or old HSC
(E) Colony composition of colonies generated from single HSCs isolated from yopathways in comparison to their downstream progenitors that
is largely age-independent. Moreover, HSC aging itself is not
associated with significant differences in the regulation of the
majority of these pathways.
DDR and Repair Pathways Are Attenuated in Quiescent,
but Not Cycling, HSCs
HSCs reside largely in a state of dormancy, >90% of them
residing in the quiescent G0 phase of the cell cycle in both young
and old mice (Figure S5) (Rossi et al., 2007b; Sudo et al., 2000),
entering into cycle infrequently throughout the adult lifespan
(Cheshier et al., 1999; Foudi et al., 2009; Wilson et al., 2008). In
contrast, downstream progenitors are more actively cycling
with a progressive increase in the steady-state cycling rate
from MPPs (Figure S5) to oligopotent progenitors (Passegue´
et al., 2005). As many DNA damage repair pathways are known
to be tightly coordinated with phases of the cell cycle, we
hypothesized that the broad attenuation of these pathways we
observed in HSCs may be due to their quiescent state. To test
this, we generated transcriptome-wide expression profiles of
HSCs isolated from the fetal liver (FL-HSCs) at embryonic day
14.5, a developmental time at which HSCs are known to be
highly cycling (Bowie et al., 2006; Morrison et al., 1995; Nygren
et al., 2006; Pietras et al., 2011), and analyzed the 190 DNA
damage repair and response genes in comparison to both young
and old adult HSCs (Figure 6A). Of the differentially expressed
genes, the vastmajority were downregulated in adult versus fetal
HSCs (Figures 6A and 6B). Consistent with this, statistical
analysis at the pathway levels also showed significant down-
regulation for the majority of the pathways for FL-HSC compar-
isons to both young and old HSCs (Figure 6C). As we had
observed in our HSC to progenitor comparisons, this skewed
expression pattern was very specific to these genes as global
analysis of all genes significantly differentially regulated between
FL-HSC and young or old HSCs showed comparable numbers of
genes up- and downregulated (Figure 6B).
The observed expression differences between FL and adult
HSCs could be explained by either intrinsic differences in
HSCs at these defined stages of ontogeny or could reflect
different cell cycle status of these cells. If the latter were true,
then cycling adult HSCs would be expected to upregulate these
pathways. To examine this, we analyzed cell-cycle status (Ki-67
and propidium iodide) of steady-state adult HSCs in conjunction
with immunostaining for Rad51. These experiments showed that
Rad51 protein expression in young and old HSCs was mainly
restricted to cells in the S/G2/M phase of the cell cycle, which,
at steady state, represents only a very small fraction of HSCs
(<2%; Figure S5). We hypothesized that adult quiescent HSCs
driven into cycle would lead to upregulation of DDR and repair
pathways as they exit G0 and progressed through cell cycle.ldmice. Numbers of cells scored daily are presented in a color scale fromwhite
s and scored for types of cells generated from each clone.
s in culture. Each clonewas assayed at time points 0.5, 1, 2, 3, 4, 5, and 6 days,
s.
ung and old mice. ***p < 0.001.
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Figure 5. Attenuation of DDR and Repair Pathways in HSCs in Comparison to Downstream Progenitor Populations
(A) Fold-change comparisons of genes involved in DDR and checkpoints (DDRC), nucleotide excision repair (NER), base excision repair (BER), mismatch repair
(MMR), nonhomologous end-joining (NHEJ), and homologous recombination (HR) in progenitor populations in comparison to their age-matched HSCs. Each
column represents an individual replicate, and the log2 fold change in comparison to the average expression of the HSCs is shown. Significant expression
changes defined as >1.5 fold and p < 0.05, are designated with a bold black boarder.
(legend continued on next page)
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Figure 6. Attenuation of DDR and Repair Genes in Quiescent HSCs
(A) Fold-change comparisons between genes involved in DDR and repair in fetal liver HSCs in comparison to adult young or old HSCs. Each column represents an
individual replicate, and the log2 fold change in comparison to the average expression of the fetal liver HSCs is shown. Significant expression changes, defined
as >1.5 fold and p < 0.05, are designated with a bold black boarder.
(B) Frequency of genes that show significant upregulation (red), significant downregulation (blue), or no significant change (gray) in each pathway for comparisons
between fetal liver HSCs and either young or old HSCs. The global frequencies of the total number of genes and those with significant differential regulation (up or
downregulated) out of the total 17,872 genes examined on the arrays are also included.
(C) Analysis of the changes of the overall pathways involved with DDR and repair in young and old HSCs in comparison to cycling fetal liver HSCs. p values are
presented by a color scale, and odds ratios < 1 are indicated with a hash through the box.
See also Figure S5.
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Quiescence Underlies Damage Accrual in Aged HSCsTo test this, we sorted HSCs from young and old mice and
cultured them for 3, 6, 12, or 24 hr in cytokine-rich media, fol-
lowed by transcriptional profiling at each time point. As ex-
pected, HSCs stimulated into cycle quickly downregulated(B) Frequency of genes that show significant upregulation (red), significant downre
between HSCs and the indicated progenitors. The global frequencies of the total n
genes examined on the arrays is also shown (global).
(C) Statistical analysis of the significance of the changes in each of the indicated
either young or old mice. p values are presented by a color scale, and odds ratio
See also Figure S4.Cdkn1c, which encodes the Cdk inhibitor p57 responsible for
maintaining HSC quiescence (Matsumoto et al., 2011; Zou
et al., 2011) (Figure 7A). Consistent with the idea that HSCs
broadly upregulate their DNA damage repair and responsegulation (blue), or no significant change (gray) in each pathway for comparisons
umber of genes showing significant differential regulation out of the total 17,872
DDR and repair pathways in progenitor cells in comparison to the HSCs from
s of less < 1 are indicated with a hash through the box.
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Figure 7. Dynamic Expression Profiles of DDR and Repair Genes in HSCs after Stimulation
(A) Fold-change comparisons of genes involved in DDR and repair in freshly purified HSCs in comparison to HSCs stimulated into cycle at different time points
(3, 6, 12, and 24 hr). Each column represents an individual replicate and the log2 fold change in comparison to the average expression of the age-corresponding
HSCs is shown. Genes with average expression fold changes > 1.5 and p < 0.05 are signified by a bold black boarder.
(B) Frequency of genes that show significant upregulation (red), significant downregulation (blue), or no significant change (gray) in each pathway in comparisons
between HSCs at steady state or 3, 6, 12, or 24 hr poststimulation for both young and old mice.
(C) Analysis of significance of the changes of the overall pathways involved with DDR and repair in stimulated HSCs in comparison to steady-state HSCs from
respective young or old mice. p values are presented by a color scale, and odds ratios < 1 are indicated with a hash through the box.
(D) Fold-change profiles of several DDR genes.
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upregulation starting at 12 hr and increasing by 24 hr post-
stimulation (Figures 7A and 7B), and most pathways are signifi-46 Cell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc.cantly upregulated by 24 hr (Figure 7C). Interestingly, we also
observed that many of the genes we examined exhibited
reduced expression at the early time points poststimulation,
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Quiescence Underlies Damage Accrual in Aged HSCswhich led to many of the pathways displaying significant down-
regulation at 3 hr, with the old cells showing attenuation of almost
all DNA response and repair pathways. This early decrease in
expression of these pathways was accompanied by robust in-
duction of a subset of DDR and checkpoint genes that included
Cdkn1a, Gadd45a, Gadd45b, Gadd45g, Trex1/Atrip, Plk3, and
Crebbp, and expression of these genes spiked at 3 hr poststim-
ulation, followed by a return to steady state levels by 12 to 24 hr
(Figure 7D). Though this pattern was evident in both young and
old HSCs, in almost all cases, we observed a greater induction
of these genes in aged HSCs (Figure 7D).
Altogether, these data indicate that DNA repair and response
pathways are broadly attenuated in quiescent, but not cycling,
HSCs. Furthermore, they suggest that HSCs exit from G0 and
progression into the cell cycle leads to induction of DNA damage
repair and response genes. The broad attenuation of DNA dam-
age repair and response pathways in quiescent HSCsmost likely
underlies the accrual of DNA damage during aging.
DISCUSSION
The lifelong potential of HSCs has led to the supposition that
these cells must be imbued with a unique ability to preserve their
genomic integrity. Indeed, many properties associated with
HSCs, such as high ABC transporter activity, low metabolic
activity, hypoxic environment, and long periods of dormancy,
are potential means through which HSCs could maintain
genomic fidelity to preserve function. However, evidence that
HSCs may not be impervious to DNA damage accrual has
been implicated in studies utilizing genetic models (Cho et al.,
2013; Nijnik et al., 2007; Parmar et al., 2010; Prasher et al.,
2005; Rossi et al., 2007a; Rudolph et al., 1999), their comparable
radiation sensitivity to other cells that undergo mitotic death
(Domen et al., 1998; Till and McCulloch, 1961), and examination
of gH2AX in HSCs (Rossi et al., 2007a; Ru¨be et al., 2011).
Moreover, increasing evidence that mutation accrual in the
HSC compartment underlies numerous age-associated hemato-
poietic malignancies, including acute myeloid leukemia (AML)
(Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan
and Majeti, 2013; Pang et al., 2013), is also inconsistent
with the idea of a privileged, exquisitely geno-protected HSC
compartment.
In opposition to the concept that HSCs are entirely geno-
protected during aging, we observed significant and consistent
evidence of DNA strand breaks in HSCs isolated from old
mice. A possible explanation for this could be that DNA repair
and/or responses may be differentially regulated in HSCs during
aging, as has previously been suggested (Chambers et al., 2007;
Ru¨be et al., 2011). However, our global examination of DNA
repair and response genes and pathways revealed minimal
differences during aging in HSCs. The sole exception to this
was the downregulation of the NER pathway in aged HSCs.
However, it seems unlikely that the observed accrual of strand
breaks in old HSCs could be attributable to diminished expres-
sion of this pathway. Nonetheless, it remains possible, and
perhaps likely, that downregulation of NER might lead to accu-
mulation of bulky DNA adducts in HSCs (that we did not evaluate
in this study) that could affect function during aging. Consistent
with this, we have previously observed an aging-dependentdecline in HSC activity in a murine model of NER deficiency
(Rossi et al., 2007a).
In further refutation of the concept that HSCs possess inherent
mechanisms that uniquely protect their genome, examination of
DNA damage accrual in multiple early progenitor cell compart-
ments in comparison to HSCs revealed that the greatest amount
of age-associated damage was concentrated in HSCs. Global
examination of DNA repair and response pathways in these
progenitors revealed that, in contrast to the minimal differences
observed between young and old HSCs, the majority of these
pathways showed robust and highly significant upregulation in
downstream progenitors regardless of age. However, we did
note that NHEJ appeared to be transcriptionally active in both
young and old HSCs, which appears inconsistent with the signif-
icant accrual of strand breaks in old HSCs that we observed in
multiple independent experiments. We speculate that the tran-
scriptional activity of NHEJ in HSCs may prime HSCs for repair
once the cells enter cycle in a manner similar to the transcrip-
tional priming of lineage potential observed in HSCs (Kirstetter
et al., 2006; Mead et al., 2013; Miyamoto et al., 2002). Consistent
with this, we observed robust repair of accrued strand breaks in
old HSCs upon stimulation and entry into cell cycle both ex vivo
and in vivo.
Exit from G0 and entry into cycle led to global upregulation of
essentially all DNA repair and response pathways. This raises the
possibility that attenuation of these pathways in quiescent HSCs
may more broadly contribute to the accrual of diverse genomic
lesions not assayed in this study, particularly given the low
turnover rate of HSCs and their prolonged periods of dormancy
(Cheshier et al., 1999; Foudi et al., 2009; Wilson et al., 2008).
Interestingly, exit from G0 was associated with robust induction
of canonical DDR genes, includingCdkn1a,Gadd45a,Gadd45b,
Gadd45g, and Rb1, shortly after entry into cycle. These data
suggest the existence of a post-G0 DNA-damage-induced
checkpoint in HSCs that we postulate may be in place to ensure
that damage accrued during periods of dormancy is repaired
prior to either differentiation or self-renewal divisions. Though
our data clearly indicates that old HSCs can repair strand breaks
upon entry into cycle, we did not address the fidelity of repair or
examine other types of DNA damage in this study, which could
also contribute to the diminished functional potential observed
with HSC aging. Moreover, it seems likely that the attenuation
of DNA repair and response pathways we observe in quiescent
HSCs could lead to age-associated mutation accrual beyond
strand breaks. Indeed, the idea that HSCs serve as the primary
reservoir for mutation accrual underlying the development of
diverse age-associated hematopoietic diseases such as myelo-
dysplastic syndrome and AML is now widely accepted (Jan
et al., 2012; Krivtsov et al., 2013; Rossi et al., 2007a; Shlush
et al., 2014; Taussig et al., 2005; Tehranchi et al., 2010; Weiss-
man, 2005; Will et al., 2012). Our data demonstrating that HSC
quiescence and concomitant attenuation of DNA repair and
response pathways provides a mechanism through which
such premalignant mutations in HSCs may accrue. It should be
stated that other adult stem cell tissue systems, such as brain,
gastrointestinal tract, skin, etc., will very likely follow the same
energy-saving paradigm, accumulate DNA damage in quiescent
stem cells, and repair these insults when it is necessary to enter
cell cycle.Cell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc. 47
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Mice
All mice used were C57BL/6 males. Young mice were 3–4 months old, and old
mice, obtained from the National Institute on Aging, were 24–26months old. All
mice were maintained according to protocols approved by Harvard Medical
School Animal Facility or Stanford University’s Administrative Panel on Labo-
ratory Animal Care, and all procedures were performed with consent from the
local ethics committees.
Purification of Cells
Adult bone marrow cells were extracted by crushing the bones of donor mice.
Cells were stained and sorted with the following cell-surface phenotypes:
HSCs, Lin(Mac1, Gr1, Ter119, B220, Il7ra, CD3, CD4, CD8)c-Kit+Sca-1+
CD34Flk2 or, when noted, Lin(Mac1, Gr1, Ter119, B220, Il7ra, CD3, CD4,
CD8)c-Kit+ Sca-1+CD150+CD48; MPPFlk2, Lin(Mac1, Gr1, Ter119, B220,
Il7ra, CD3, CD4, CD8)c-Kit+Sca1+CD34+Flk2; MPPFlk2+, Lin(Mac1, Gr1,
Ter119, B220, Il7ra, CD3, CD4, CD8) c-Kit+Sca-1+CD34+Flk2+; GMP, Lin
(Mac1, Gr1, Ter119, B220, Il7ra, CD3, CD4, CD8)c-Kit+Sca1CD34+FcgR+;
CLP, Lin(Mac1, Gr1, Ter119, CD3, CD4, CD8)CD19CD11cB220-CD27+
c-KitmidFlk2+IL7Ra+Ly6d; CMP, Lin(Mac1, Gr1, Ter119, B220, Il7ra, CD3,
CD4, CD8)c-Kit+Sca-1CD34+FcgRlow; MEP, Lin(Mac1, Gr1, Ter119, B220,
Il7ra, CD3, CD4, CD8)c-Kit+Sca-1CD34 FcgR; BLP, Lin(Mac1, Gr1,
Ter119, CD3, CD4, CD8)CD19CD11c B220CD27+ c-Kitmid Flk2+IL7Ra+
Ly6d+; and pre-ProB, Lin(Mac1, Gr1, Ter119, CD3, CD4, CD8)
CD19CD11cB220+CD27+c-KitmidFlk2+IL7Ra+Ly6d+. All cells were sorted
on a FACSAria II (Becton Dickinson), and propidium iodide was used to
exclude dead cells. FACS data were analyzed with FlowJo (Tree Star).
Comet Assays
Alkaline comet assays were performed with Trevigen CometAssay kits and
slides according to the manufacturer’s protocols. In brief, purified cells were
embedded in Comet LM Agarose and transferred onto Trevigen HT Comet-
Slides. For each experiment, all cells used in comparison analyses were
assayed on a single high-throughput slide such that all of the following steps
were consistent for those comparisons. The immobilized cells were lysed
overnight and treated with freshly made alkaline unwinding solution followed
by electrophoresis in alkaline conditions with the Trevigen CometAssay
Electrophoresis System. Cells were stained with SYBR Green or SYBR Gold
and imaged. Analysis was performed on blinded files with CometScore
(TriTek), where values for percent tail DNA and Olive moment were generated.
Control HSCs received 2 Gy of gamma irradiation. Statistical significance was
calculated in Prism (GraphPad) utilizing the Mann-Whitney test for compari-
sons of two populations (young to old HSCs) and one-way ANOVA for HSCs
to multiple downstream progenitor populations.
In Vivo Stimulation of HSCs
Aged mice received either two doses of 5-FU (150 mg/kg) or PBS by intraper-
itoneal injection. The mice were given 3-week intervals between injections,
and bone marrow was harvested three weeks after the last injection for isola-
tion of HSCs used in comet assays. In the transplant setting, 100 HSCs
(LSKCD34Flk2) were purified from either young or old donor (CD45.2)
mice and competitively transplanted against 200,000 whole-bone-marrow
cells (CD45.1) into lethally irradiated young recipient mice (CD45.1). Donor-
derived (CD45.2) HSCs were purified and assayed for DNA damage 12months
posttransplant.
Microarray Expression Analysis
Genome-wide gene expression analysis was performed with the Affymetrix
GeneChip Mouse Genome 430 2.0 Array platform. RNA was isolated with
TRIzol (Life Technologies), and purified RNA was amplified, labeled, hybrid-
ized, and scanned according to Affymetrix’s specifications at Stanford Protein
and Nucleic Acid Facility. Raw microarray data were submitted to Gene
Expression Commons (https://gexc.stanford.edu) (Seita et al., 2012), where
data normalization was computed against the Common Reference, which is
a large collection (n = 11,939) of publically available microarray data from
the National Center for Biotechnology Information Gene Expression Omnibus
(NCBI GEO). Meta-analysis of the Common Reference also provides the dy-48 Cell Stem Cell 15, 37–50, July 3, 2014 ª2014 Elsevier Inc.namic range of each probe set on the array, and, in situations where there
are multiple probe sets for the same gene, the probe set with widest dynamic
range was used for analysis. The Affymetrix Mouse Genome 430 2.0 Array in-
cludes 45,101 probesets, of which 17,872 annotated genes are measurable.
Heat maps representing fold change of gene expression were generated in
Gene Expression Commons. Pair-wise statistical comparisons at the gene
level between cell types was computed with Significance Analysis of Micro-
array (Tusher et al., 2001) provided in R genes with the criteria FDR < 0.05
and fold change > 1.5 were scored as significant genes, and results were
merged into Gene Expression Commons.
Pathway-level statistical comparison was performed by Fisher’s exact test
in Gene Expression Commons in which the frequency of significantly upregu-
lated or downregulated genes was compared between genes in the pathway
and in all of the other annotated genes on the microarray.
All normalized expression intensities, results of statistical comparisons, and
heatmap representations are available atGeneExpressionCommonsasHSCs
and progenitors young versus old (https://gexc.stanford.edu/model/detail/
786), FL-young-old HSCs (https://gexc.stanford.edu/model/detail/775), and
HSCs in vitro stimulation (https://gexc.stanford.edu/model/detail/313).
Clonal Ex Vivo Stimulation Assay
Using the single-cell mode of the FACSAria, we sorted cells individually into a
single well of a 96-well round-bottom plate. For each experiment, 120 wells
were used with three replicates of each age group. Each well contained
Dulbecco’smodified Eagle’smedium and F-12medium (Gibco and Invitrogen)
supplemented with 10% fetal calf serum (Hyclone and Thermo Scientific), 13
penicillin/streptomycin, 2 mM GlutaMAX, 50 mM 2-mercaptoethanol (Gibco
and Invitrogen), and the following cytokines: 10 ng/ml mouse stem cell factor,
10 ng/ml mouse thrombopoietin, 10 ng/ml mouse Flt3l, 10 ng/ml mouse IL-3,
1 U/ml mouse erythropoietin, 10 ng/ml mouse granulocyte macrophage
colony-stimulating factor (all purchased from PeproTech). The cells were incu-
bated at 37C in a humidified atmosphere with 5% CO2. At 12, 24, 48, 72, 96,
120, and 144 hr of culture, cell numbers in each well were counted under
microscope. After 12 days of culture, the size of each colony was measured
under a microscope, and colonies were subjected to cytospin and character-
izedmorphologically and cytochemically byMay-Gruenwald-Giemsa staining.
The same culture conditions were used for short-term ex vivo stimulation of
pooled cells (Figures 3A and 7).
ACCESSION NUMBERS
Raw data were been deposited to the NCBI GEO under accession number
GSE55525.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2014.04.016.
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